EW vs SO · P/E 47, rev $1.39B vs P/E 22, rev $29.55B
Edwards Lifesciences Corp (EW) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the EW and SO stock pages for the full models.
Not investment advice.